Forecasting
Revolutionising Gene Therapy with Strategic Conjoint Insights
Commercial
Challenge:
Gene therapy in haemophilia, 2nd/3rd entry with superior profile
Positioning hurdles due to previous therapies
A need to identify opportunities for a novel later-entry gene therapy within current market dynamics
solution
1.
Qualitative market landscaping and TPP Assessment
2.
Conjoint analysis with integrated order of entry assessment
3.
Co-creation workshop with marketing and forecasting teams
Delivered
1.
Gold standard conjoint simulator
2.
Integrated uptake curves and order of entry considerations
3.
Forecast simulator training and immersion with various ‘what if’ scenarios
Result
Empowered team to maximise potential of their gene therapy with a comprehensive tool for forecasting and strategic decision making.